Inger Sandlie • 1953 • Oslo • 8 roles • 6 shareholdings

This website uses cookies to enhance the user experience.

Roles

Boards

Name	Role	Total operating income	Total equity	Shares
S SANDLIE AS	Contact Person	30,000	73,176	100 % directly
J JTIS AS	Board Member	-	-1,767	33 % indirectly
A AUTHERA AS	Board Member	12,512,274	3,808,397	9.7 % indirectly
A AUTHERA HOLDING AS	Board Member	-	130,000	9.7 % indirectly
I INVEN2 AS	Board Member	83,852,000	178,779,000	-
R RADFORSK INVESTERINGSSTIFTELSE	Board Member	5,374,000	81,697,000	-
S SUPERIO BIO AS	Chairman	-	-	-

Last update: Jun 26, 2025

Related industries3

Direct relationships5

JT
Jan Terje Andersen1978
AUTHERA AS, JTIS AS, AUTHERA HOLDING AS, SUPERIO BIO AS
SM
Simone Mester1993
AUTHERA AS, AUTHERA HOLDING AS
EB
Erlend Bremertun Smeland1955
INVEN2 AS, RADFORSK INVESTERINGSSTIFTELSE
TT
Torleif Tollefsrud Gjølberg1993
AUTHERA AS, AUTHERA HOLDING AS
BE
Benedicte Elisabeth Bakke Agerup1964
INVEN2 AS

Shares owned by Inger Sandlie

Name	Share class	Total operating income	Total equity	Share
S SANDLIE AS	Ordinære aksjer	30,000	73,176	100 % directly
J JTIS AS		0	-1,767	33 % indirectly
A AUTHERA AS		12,512,274	3,808,397	9.7 % indirectly
A AUTHERA HOLDING AS		0	130,000	9.7 % indirectly
N NEXTERA AS	NO0010848534	9,063,500	18,914,344	0.67 % directly 0.67 % indirectly 0.08 %
N NYKODE THERAPEUTICS ASA	NO0010714785	9,158,000	140,142,000	0.02 % directly < 0.01 %

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025